Bimatoprost versus mometasone furoate in the treatment of scalp alopecia areata: A pilot study

Dermatology

Volumn 230, Issue 4, 2015, Pages 308-313

  Zaher, Hesham ^a   Gawdat, Heba I ^a   Hegazy, Rehab A ^a   Hassan, Marwa ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Alopecia areata; Bimatoprost; Corticosteroids; Efficacy; Side effects

Indexed keywords

BIMATOPROST; MOMETASONE FUROATE; DERMATOLOGICAL AGENT; SKIN CREAM;

ABSENCE OF SIDE EFFECTS; ADULT; ALOPECIA AREATA; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE EFFECTIVENESS; CREAM; DISEASE SEVERITY ASSESSMENT; DRUG EFFICACY; DRUG SAFETY; DRUG SOLUTION; FEMALE; FOLLOW UP; HUMAN; MALE; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PILOT STUDY; PRIORITY JOURNAL; SEVERITY OF ALOPECIA TOOL; COMPARATIVE STUDY; CONTROLLED STUDY; CUTANEOUS DRUG ADMINISTRATION; GROWTH, DEVELOPMENT AND AGING; HAIR; MIDDLE AGED; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCALP; SEVERITY OF ILLNESS INDEX; SINGLE BLIND PROCEDURE; YOUNG ADULT;

ADMINISTRATION, CUTANEOUS; ADULT; ALOPECIA AREATA; BIMATOPROST; DERMATOLOGIC AGENTS; FEMALE; HAIR; HUMANS; MALE; MIDDLE AGED; MOMETASONE FUROATE; PILOT PROJECTS; PROSPECTIVE STUDIES; SCALP; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; SKIN CREAM; YOUNG ADULT;

EID: 84988233554     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000371416     Document Type: Article

References (24)

1. Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J: Alopecia areata update. J Am Acad Dermatol 2010; 62: 191-202
2. Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ 3rd: Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc 1995; 70: 628-633
3. Alkhalifah A: Topical and intralesional therapies for alopecia areata. Dermatol Ther 2011; 24: 355-363
4. Delamere FM, Sladden MJ, Dobbins HM, Leonardi-Bee J: Interventions for alopecia areata. Cochrane Database Syst Rev 2008; 2: CD004413
5. Messenger AG, McKillop J, Farrant P, Mc-Donagh AJ, Sladden M: British Association of Dermatologists' guidelines for the management of alopecia areata 2012. Br J Dermatol 2012; 166: 916-926
6. Johnstone MA. Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost. Am J Ophthalmol 1997; 124: 544-547
7. Wand M: Latanoprost and hyperpigmentation of eyelashes. Arch Ophthalmol 1997; 115: 1206-1208
8. Ochoa BE, Sah D, Wang G, Stamper R, Price VH. Instilled bimatoprost ophthalmic solution in patients with eyelash alopecia areata. J Am Acad Dermatol 2009; 60: 530-532
9. Roseborough I, Lee H, Chwalek J, Stamper R, Price VH. Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata. J Am Acad Dermatol 2009; 60: 705-706
10. Faghihi G, Andalib F, Asilian A: The efficacy of latanoprost in the treatment of alopecia areata of eyelashes and eyebrows. Eur J Dermatol 2009; 19: 586-587
11. Coronel-Perez IM, Rodriguez-Rey EM, Camacho-Martinez FM. Latanoprost in the treatment of eyelash alopecia in alopecia areata universalis. J Eur Acad Dermatol Venereol 2010; 24: 481-485
12. Zaheri S, Hughes B: Successful use of bimatoprost in the treatment of alopecia of the eyelashes. Clin Exp Dermatol 2010; 35: e161-e162
13. Olsen EA, Hordinsky MK, Price VH, Roberts JL, Shapiro J, Canfield D, Duvic M, King LE Jr, McMichael AJ, Randall VA, Turner ML, Sperling L, Whiting DA, Norris D; National Alopecia Areata Foundation: Alopecia areata investigational assessment guidelines - Part II. National Alopecia Areata Foundation. J Am Acad Dermatol 2004; 51: 440-447
14. Gilhar A, Etzioni A, Paus R: Alopecia areata. N Engl J Med 2012; 366: 1515-1525
15. Tosti A, Piraccini BM, Pazzaglia M, Vincenzi C: Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis. J Am Acad Dermatol 2003; 49: 96-98
16. Khidhir KG, Woodward DF, Farjo NP, Farjo BK, Tang ES, Wang JW, Picksley SM, Randall VA. The prostamide-related glaucoma therapy, bimatoprost, offers a novel approach for treating scalp alopecias. FASEB J 2013; 27: 557-567
17. Thibaut S, De Becker E, Caisey L, Baras D, Karatas S, Jammayrac O, Pisella PJ, Bernard BA. Human eyelash characterization. Br J Dermatol 2010; 162: 304-310
18. Randall VA. Hormonal regulation of hair follicles exhibits a biological paradox. Semin Cell Dev Biol 2007; 18: 274-285
19. Li N, Chen XM, Zhou Y, Wei ML, Yao X: Travoprost compared with other prostaglandin analogues or timolol in patients with openangle glaucoma or ocular hypertension: metaanalysis of randomized controlled trials. Clin Experiment Ophthalmol 2006; 34: 755-764
20. Cohen JL. Enhancing the growth of natural eyelashes: the mechanism of bimatoprost-induced eyelash growth. Dermatol Surg 2010; 36: 1361-1371
21. Vila TO, Camacho Martinez FM. Bimatoprost in the treatment of eyelash universalis alopecia areata. Int J Trichology 2010; 2: 86-88
22. Johnstone MA, Albert DM. Prostaglandininduced hair growth. Surv Ophthalmol 2002; 47(suppl 1): S185-S202
23. Gandolfi S, Simmons ST, Sturm R, Chen K, VanDenburgh AM; Bimatoprost Study Group 3: Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension. Adv Ther 2001; 18: 110-121
24. Law SK. Bimatoprost in the treatment of eyelash hypotrichosis. Clin Ophthalmol 2010; 4: 349-358